Medicines Evaluation Board

About

In recent decades, authors affiliated with Medicines Evaluation Board have published 761 papers, which have received a total of 17.2k indexed citations. Scholars at this organization have produced 219 papers in Economics and Econometrics, 160 papers in Pediatrics, Perinatology and Child Health and 97 papers in Molecular Biology on the topics of Health Systems, Economic Evaluations, Quality of Life (165 papers), Pharmaceutical studies and practices (144 papers) and Pharmaceutical Economics and Policy (120 papers). Their work is cited by papers focused on Molecular Biology (3.6k citations), Economics and Econometrics (2.6k citations) and Pediatrics, Perinatology and Child Health (2.1k citations). Authors at Medicines Evaluation Board collaborate with scholars in Netherlands, United States and Germany and have published in prestigious journals including New England Journal of Medicine, The Lancet and Nucleic Acids Research. Some of Medicines Evaluation Board's most productive authors include Sabine M. J. M. Straus, Hubert G. M. Leufkens, Bruno H. Stricker, Marcel Kwa, Miriam Sturkenboom, Carla Herberts, Aukje K. Mantel‐Teeuwisse, Jan Willem van der Laan, Peter G. M. Mol and Toine C. G. Egberts.

In The Last Decade

Medicines Evaluation Board

712 papers receiving 17.2k citations

Fields of papers published by authors at Medicines Evaluation Board

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers affiliated with Medicines Evaluation Board at the time of their publication. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers affiliated with Medicines Evaluation Board at the time of their publication.

Countries citing scholars working at Medicines Evaluation Board

Since Specialization
Citations

This map shows the geographic impact of research produced by authors working at Medicines Evaluation Board. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by papers produced at Medicines Evaluation Board with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Medicines Evaluation Board more than expected).

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar’s output or impact.

Explore institutions with similar magnitude of impact

Rankless by CCL
2026